MedTrace Logo

Prostate Reirradiation Toxicity Outcomes Feasibility Study

NCT05614700 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-11-15

No results posted yet for this study

Summary

The RO-PIP trial aims to determine the feasibility of recruitment to a trial randomising patients to salvage ultra-hypofractionated external beam radiotherapy or high dose rate brachytherapy and provide prospective data on patient recorded toxicity outcomes that will inform a future phase III trial.

Conditions

Interventions

RADIATION

Brachytherapy

High Dose-Rate Brachytherapy

RADIATION

Sterotactic Body Radiotherapy

Hypofractionated External Beam Radiotherapy

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Ann Henry · University of Leeds

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2024-11-15
Completion
2026-11-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05614700 on ClinicalTrials.gov